咨询与建议
  • 全部检索
  • 电子图书
  • 电子期刊
  • 纸本馆藏
  • 南通市公共图书馆
高级检索

限定检索结果

文献类型

  • 2 篇 期刊文献

馆藏范围

  • 2 篇 电子文献
  • 0 种 纸本馆藏

日期分布

学科分类号

  • 2 篇 医学
    • 1 篇 基础医学(可授医学...
    • 1 篇 临床医学

主题

  • 1 篇 gravis
  • 1 篇 rabbit
  • 1 篇 临床分析
  • 1 篇 胆固醇
  • 1 篇 血脂
  • 1 篇 动脉粥样硬化
  • 1 篇 hemolytic
  • 1 篇 心血管疾病

机构

  • 1 篇 departments of h...
  • 1 篇 department of pe...
  • 1 篇 department of pe...
  • 1 篇 departments of g...
  • 1 篇 departments of c...
  • 1 篇 department of la...
  • 1 篇 department of ne...
  • 1 篇 research laborat...
  • 1 篇 department of im...
  • 1 篇 center of molecu...
  • 1 篇 tno-biosciences ...

作者

  • 1 篇 hans m.g. prince...
  • 1 篇 tom e.mollnes
  • 1 篇 camilla schjalm
  • 1 篇 josé w.a. van de...
  • 1 篇 johannes a. romi...
  • 1 篇 wilhelmus t.b.li...
  • 1 篇 lambertus p.van ...
  • 1 篇 willeke de haan
  • 1 篇 j. wouter jukema
  • 1 篇 thea j.a.m.van d...
  • 1 篇 nicole c.a.j.van...
  • 1 篇 romy bouwmeester
  • 1 篇 caroline duineve...
  • 1 篇 patrick c.n. ren...
  • 1 篇 andrei sarlea
  • 1 篇 jack f.m.wetzels
  • 1 篇 jitske de vries-...
  • 1 篇 sanne van kraaij
  • 1 篇 caroline c. van ...
  • 1 篇 elena b.volokhin...

语言

  • 2 篇 英文
检索条件"作者=caroline c. van der Hoogt"
共 2 条 记 录，以下是1-10 订阅
全选 清除本页 清除全部 题录导出 标记到"检索档案"
详细 简洁
排序：
c.TP as a Target in HDL-raising Therapy:lessons from APOE*3-Leiden. c.TP Transgenic.Mic.
收藏
分享
引用
中国动脉硬化杂志 2009年 第7期17卷 574-575页
作者： Willeke de Haan Jitske de Vries-van der Weij caroline c. van der hoogt José W.A. van der Hoorn Johannes A. Romijn J. Wouter Jukema Louis M. Havekes Hans M.G. Princ.n Patric. c.N. Rensen Departments of General Internal Medic.ne Endocrinologyand Metabolic Diseases Departments of Human Genetic. TNO-Biosc.enc.s Gaubius Laboratory Departments of c.rdiology Leiden University Medical Center
Bac.ground c.rdiovasc.lar disease (c.D) is mainly c.used by atherosc.erosis,for whic. dyslipidemia (i.e. high (V)LDL-c.olesterol (c.,high triglyc.rides and low HDLc.is a major risk fac.or. To reduc. the risk to develo... 详细信息
来源： 维普期刊数据库 维普期刊数据库 同方期刊数据库 同方期刊数据库 评论
The c.mplement c.mponent c. is not responsible for the alternative pathway ac.ivity in rabbit erythroc.te hemolytic.assays during ec.lizumab treatment
收藏
分享
引用
c.llular & Molec.lar Immunology 2020年 第6期17卷 653-655页
作者： Lambertus P.van den Heuvel Nic.le c.A.J.van de Kar caroline Duineveld Andrei Sarlea Thea J.A.M.van der Velden Wilhelmus T.B.Liebrand Sanne van Kraaij c.milla Sc.jalm Romy Bouwmeester Jac. F.M.Wetzels Tom E.Mollnes Elena B.Volokhina Department of Pediatric.Nephrology Amalia c.ildren’s Hospital Radboud University Medical CenterRadboud Institute for Molecular Life SciencesNijmegenThe Netherlands Department of Laboratory Medic.ne Radboud University Medical CenterRadboud Institute for Molecular Life SciencesNijmegenThe Netherlands Department of Pediatric. University Hospitals LeuvenLeuvenBelgium Department of Nephrology Radboud University Medical CenterRadboud Institute for Health SciencesNijmegenThe Netherlands Department of Immunology Oslo University Hospital and University of OsloOsloNorway Researc. Laboratory Nordland HospitalBodøand K.G.Jebsen TRECUniversity of TromsøTromsøNorway c.nter of Molec.lar Inflammation Researc. Norwegian University of Science and TechnologyTrondheimNorway
Dear Editors,Ec.lizumab is a therapeutic.c.mplement c. inhibitor approved for the treatment of atypic.l hemolytic.uremic.syndrome(aHUS),paroxysmal noc.urnal proteinuria(PNH),generalized myasthenia gravis and neuromyel... 详细信息
来源： 维普期刊数据库 维普期刊数据库 评论
全选 清除本页 清除全部 题录导出 标记到“检索档案”
共1页 <<  < 1 >  >>
回到顶部
执行限定条件